Tag: BioSolutions
EBS 6-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors...
SAN FRANCISCO, June 12, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more...
COVID-19 Vaccine Drug Substance Manufactured by Emergent BioSolutions Authorized as Part...
Emergent continues to work with the FDA to address identified observations at Bayview facility in order to release additional batches and resume production...
Investor Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds...
RADNOR, Pa., June 11, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that the...
EBS Investor Reminder: Kessler Topaz Meltzer & Check, LLP Announces Deadline...
RADNOR, Pa., June 07, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds Emergent BioSolutions...
Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Emergent BioSolutions...
RADNOR, Pa., June 03, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that the...
HAGENS BERMAN Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm...
SAN FRANCISCO, June 01, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more...
EBS DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP – Important...
RADNOR, Pa., May 30, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds Emergent BioSolutions...
Emergent BioSolutions Announces Positive Two-Year Persistence Data From Phase 2 Study...
A dose-related increase in immune response, as measured by anti-chikungunya virus serum neutralizing antibodies (SNA), was previously observed. Two years post-vaccination, SNA mean...